25. Ghayor C, Ehrbar M, San Miguel B, Gra¨tz KW, Weber FE (2009) cAMP enhances BMP2-signaling through PKA and MKP1-dependent mechanisms. Biochem Biophys Res Commun 381: 247–252. 26. Nakao Y, Koike T, Ohta Y, Manaka T, Imai Y, et al. (2009) Parathyroid hormone enhances bone morphogenetic protein activity by increasing intracellular 39, 59-cyclic adenosine monophosphate accumulation in osteoblastic MC3T3-E1 cells. Bone 44: 872–877. 27. Kinoshita T, Kobayashi S, Ebara S, Yoshimura Y, Horiuchi H, et al. (2000) Phosphodiesterase inhibitors, pentoxifylline and rolipram, increase bone mass mainly by promoting bone formation in normal mice. Bone 27: 811–817. 28. Horiuchi H, Saito N, Kinoshita T, Wakabayashi S, Tsutsumimoto T, et al. (2001) Enhancement of bone morphogenetic protein-2-induced new bone formation in mice by the phosphodiesterase inhibitor pentoxifylline. Bone 28: 290–294. 29. Horiuchi H, Saito N, Kinoshita T, Wakabayashi S, Yotsumoto N, et al. (2002) Effect of phosphodiesterase inhibitor-4, rolipram, on new bone formations by recombinant human bone morphogenetic protein-2. Bone 30: 589–593. 30. Chandhoke TK, Huang YF, Liu F, Gronowicz GA, Adams DJ, et al. (2008) Osteopenia in transgenic mice with osteoblast-targeted expression of the inducible cAMP early repressor. Bone 43: 101–109. 31. Wozney JM, Rosen V, Celeste AJ, Mitsock LM, Whitters MJ, et al. (1988) Novel regulators of bone formation: molecular clones and activities. Science 242: 1528–1534. 32. Rosen V, Nove J, Song JJ, Thies RS, Cox K, et al. (1994) Responsiveness of clonal limb bud cell lines to bone morphogenetic protein 2 reveals a sequential relationship between cartilage and bone cell phenotypes. J Bone Miner Res 9: 1759–1768. 33. Zhao M, Harris SE, Horn D, Geng Z, Nishimura R, et al. (2002) Bone morphogenetic protein receptor signaling is necessary for normal murine postnatal bone formation. J Cell Biol 157: 1049–1060. 34. Ionescu AM, Drissi H, Schwarz EM, Kato M, Puzas JE, et al. (2004) CREB Cooperates with BMP-stimulated Smad signaling to enhance transcription of the Smad6 promoter. J Cell Physiol 198: 428–440. 35. Zhao M, Edwards RJ, Ko SY, Parlato S, Harris SE, et al. (2009) CREB induces BMP2 transcription in osteoblasts and CREB knockout reduces bone mass in mice. Bone 44(suppl 1): S27. 36. Liu H, Zhang RR, Dong SS, Edwards J, Ko SY, et al. (2010) Contributions of PTH-mediator CREB to postnatal bone mass in human and mouse through regulation of osteoblast function. ASBMR 2010 Annual Meeting at Toronto, Canada, Oral presentation, #1221. 37. Impey S, McCorkle SR, Cha-Molstad H, Dwyer JM, Yochum GS, et al. (2004) Defining the CREB regulon: a genome-wide analysis of transcription factor regulatory regions. Cell 119: 1041–1054. 38. Zhao M, Qiao M, Oyajobi BO, Mundy GR, Chen D (2003) E3 Ubiquitin ligase Smurf1 mediates Cbfa1 degradation and plays a specific role in osteoblast differentiation. J Biol Chem 278: 27939–27944. 39. Zhao M, Qiao M, Harris SE, Chen D, Oyajobi BO, et al. (2006) The zinc finger transcription factor Gli2 mediates bone morphogenetic protein 2 expression in osteoblasts in response to hedgehog signaling. Mol Cell Biol 26: 6197–6208. CREB Activates BMP2 Expression in Osteoblasts 40. Zhao M, Ko SY, Liu JH, Chen D, Wang BL, et al. (2009) Inhibition of microtubule assembly in osteoblasts stimulates BMP-2 expression and bone formation through the transcription factor Gli2. Mol Cell Biol 29: 1291–1305. 41. Persengiev SP, Green MR (2003) The role of ATF/CREB family members in cell growth, survival and apoptosis. Apoptosis 8: 225–218. 42. Yang X, Matsuda K, Bialek P, Jacquot S, Masuoka HC, et al. (2004) ATF4 is a substrate of RSK2 and an essential regulator of osteoblast biology; implication for Coffin-Lowry Syndrome. Cell 117: 387–398. 43. Han CY, Wang Y, Yu L, Powers D, Xiong X, et al. (2009) Small Molecules with potent osteogenic-inducing activity in osteoblast cells. Bioorg Med Chem Lett 19: 1442–1445. 44. Yadav VK, Ryu JH, Suda N, Tanaka KF, Gingrich JA, et al. (2008) Lrp5 controls bone formation by inhibiting serotonin synthesis in the duodenum. Cell 135: 825–837. 45. Blois JT, Mataraza JM, Mecklenbra u¨ker J, Tarakhovsky A, Chiles TC (2004) B cell receptor-induced cAMP-response element-binding protein activation in B lymphocytes requires novel protein kinase Cdelta. J Biol Chem 279: 30123–30132. 46. Solomou EE, Juang YT, Tsokos DC (2001) Protein kinase C-theta participates in the activation of cyclic AMP-responsive element-binding protein and its subsequent binding to the 2180 site of the IL-2 promoter in normal human T lymphocytes. J Immunol 166: 5665–5674. 47. Garrett IR, Chen D, Gutierrez G, Zhao M, Escobedo A, et al. (2003) Selective inhibitors of the osteoblast proteasome stimulate bone formation in vivo and in vitro. J Clin Invest 111: 1771–1782. 48. Zhao M, Qiao M, Chen D, Harris SE, Oyajobi OB, et al. (2005) b-catenin is a powerful enhancer of BMP-2 gene expression in osteoblasts in vitro and in vivo. Bone 36(Suppl 2): S142. 49. Su JL, Yang CY, Zhao M, Kuo ML, Yen ML (2007) Forkhead proteins are critical for bone morphogenetic protein-2 regulation and anti-tumor activity of resveratrol. J Biol Chem 282: 19385–19398. 50. Groppe J, Greenwald J, Wiater E, Rodriguez-Leon J, Economides AN, et al. (2002) Structural basis of BMP signalling inhibition by the cystine knot protein Noggin. Nature 420: 636–642. 51. Groppe J, Greenwald J, Wiater E, Rodriguez-Leon J, Economides AN, et al. (2003) Structural basis of BMP signaling inhibition by Noggin, a novel twelve- membered cystine knot protein. J Bone Joint Surg Am 85: 52–58. 52. Lee YS, Chuong CM (1997) Activation of protein kinase A is a pivotal step involved in both BMP-2- and cyclic AMP-induced chondrogenesis. J Cell Physiol 170: 153–165. 53. Cardinaux JR, Notis JC, Zhang Q, Vo N, Craig JC, et al. (2000) Recruitment of CREB binding protein is sufficient for CREB-mediated gene activation. Mol Cell Biol 20: 1546–1552. 54. Ghosh-Choudhury N, Windle JJ, Koop BA, Harris MA, Guerrero DL, et al. (1996) Immortalized murine osteoblasts derived from BMP 2-T-antigen expressing transgenic mice. Endocrinology 137: 331–339. 55. Mantamadiotis T, Lemberger T, Bleckmann SC, Kern H, Kretz O, et al. (2000) Disruption of CREB function in brain leads to neurodegeneration. Nat Genet 31: 47–54. PLoS ONE | www.plosone.org 12 June 2011 | Volume 6 | Issue 6 | e20780